Aleon Pharma International, Inc.转发了
Congratulations to BeiGene on its impressive growth in 2024 and the continued success of its lead medicine, BRUKINSA??(zanubrutinib)?! I vividly remember the day when Aleon collaborated with the BeiGene team for the pre-IND meeting with the FDA a decade ago, setting the stage for many significant regulatory milestones. It’s been an honor to support the development of this medicine, which has made a profound impact on patients’ lives. In the 15 years since Aleon’s founding in 2010, we’ve proudly supported over 115 IND programs. Three of these programs have received FDA NDA approvals, and one is currently under FDA’s Priority Review. We’re confident that more investigational programs will achieve NDA/BLA approvals in the future. We are deeply grateful to be part of this journey. Through strong collaborations, we’re helping bring medicines to address unmet medical needs. Your Vision, Our Expertise, A Shared Future.